PrEP Implementation: Populations, Providers, and Policies

PrEP Implementation: Populations, Providers, and Policies

Apply to Register

Presenters

Hyman Scott, MD, MPH
University of California San Francisco

Start

November 19, 2019 - 10:00 AM

End

November 19, 2019 - 11:15 AM

Overview

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing sexually transmitted infections (STIs) as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will review the evidence on the use of daily and “2-1-1” PrEP and implementation within clinical settings. Further, it will discuss challenges and successes with PrEP implementation in reaching populations most at-risk for HIV acquisition including youth, Black and Latino men who have sex with men, and transgender individuals. Finally, it will discuss health provider and health system barriers and facilitators to PrEP implementation along with innovative strategies to improve uptake and persistence.

Learning Objectives

On completion of this webinar, learners will be able to:

  • Describe the evidence for PrEP
  • Describe PrEP implementation in clinical settings in the US
  • Describe the challenges in PrEP uptake and persistence

Registration

Who Should Attend

This advanced webinar is designed for physicians who are actively involved in HIV and care and research. It is also relevant for registered nurses, PharmDs, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Monday, November 18, 2019, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines a commercial interest as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.”

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credits

This activity is eligible for ANCC credit; see the final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logo This activity is eligible for ACPE credit; see the final CPE activity announcement for specific details.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.

PLATINUM SUPPORTERS
Gilead Sciences, Inc
ViiV Healthcare

GOLD SUPPORTER
Merck & Co, Inc

SILVER SUPPORTER
Cepheid

Additional support has been provided by
Hologic

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.